Massachusetts Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-95,547
| Closed | -$1.77M | – | 884 |
|
|
2023
Q3 | $1.77M | Buy |
95,547
+22,802
| +31% | +$258K | ﹤0.01% | 733 |
|
|
2023
Q2 | $805K | Sell |
72,745
-1,714
| -2% | -$23.9K | ﹤0.01% | 768 |
|
|
2023
Q1 | $1,000K | Sell |
74,459
-85,004
| -53% | -$1.47M | ﹤0.01% | 759 |
|
|
2022
Q4 | $1.97M | Buy |
159,463
+3,376
| +2% | +$47.8K | ﹤0.01% | 729 |
|
|
2022
Q3 | $2.18M | Sell |
156,087
-1,423
| -0.9% | -$22.9K | ﹤0.01% | 711 |
|
|
2022
Q2 | $2.17M | Buy |
157,510
+795
| +0.5% | +$12.7K | ﹤0.01% | 714 |
|
|
2022
Q1 | $2.55M | Buy |
156,715
+1,607
| +1% | +$25.2K | ﹤0.01% | 731 |
|
|
2021
Q4 | $2.53M | Buy |
155,108
+102,965
| +197% | +$1.74M | ﹤0.01% | 753 |
|
|
2021
Q3 | $774K | Buy |
+52,143
| New | +$834K | ﹤0.01% | 852 |
|
|
2016
Q2 | – | Sell |
-51,588
| Closed | -$6.63M | – | 881 |
|
|
2016
Q1 | $6.63M | Sell |
51,588
-13,056
| -20% | -$1.54M | ﹤0.01% | 613 |
|
|
2015
Q4 | $9.65M | Sell |
64,644
-449
| -0.7% | -$76K | 0.01% | 593 |
|
|
2015
Q3 | $10.8M | Sell |
65,093
-14,489
| -18% | -$3.19M | 0.01% | 586 |
|
|
2015
Q2 | $19.2M | Sell |
79,582
-8,616
| -10% | -$2.29M | 0.01% | 533 |
|
|
2015
Q1 | $24.9M | Buy |
88,198
+1,986
| +2% | +$430K | 0.01% | 478 |
|
|
2014
Q4 | $13.4M | Buy |
+86,212
| New | +$15.9M | 0.01% | 591 |
|
|
2014
Q2 | – | Sell |
-4,400
| Closed | -$1.45M | – | 924 |
|
|
2014
Q1 | $1.45M | Buy |
+4,400
| New | +$1.48M | ﹤0.01% | 726 |
|
Massachusetts Financial Services's ICPT Position: Q4 2023 in Review
Massachusetts Financial Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 95,547 shares — an estimated $1.77M sold.
Massachusetts Financial Services first reported a position in ICPT in Q1 2014 and held it in 16 quarters. The position peaked at $24.9M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Massachusetts Financial Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Massachusetts Financial Services sold 95,547 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.77M.
- Massachusetts Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 16 quarters.
- Massachusetts Financial Services's Intercept Pharmaceuticals, Inc. position peaked at $24.9M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Massachusetts Financial Services's 13F filing for Q4 2023, filed 8 Feb 2024.